Eulji University Reports Findings in Hemodialysis (A comparative study of epidemiological characteristics, treatment outcomes, and mortality among patients undergoing hemodialysis by health insurance types: data from the Korean Renal Data System): Dialysis – Hemodialysis

2023 OCT 16 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News -- New research on Dialysis - Hemodialysis is the subject of a report. According to news originating from Daejeon, South Korea, by NewsRx correspondents, research stated, “The prevalence of end-stage renal disease (ESRD) requiring dialysis has progressively increased. Therefore, to achieve financial stability by managing the increasing numbers of patients undergoing hemodialysis (HD), a fixed-payment system was introduced in 2001 for medical aid (MA) beneficiaries receiving HD in Korea.”

Our news journalists obtained a quote from the research from Eulji University, “We identified patients in the Korean Renal Data System that received HD between 2001 and 2017 and stratified them into the following two groups: the National Health Insurance (NHI) and MA groups. Then, we compared the two groups that differed in demographic characteristics, the treatment process and outcomes, and mortality based on health insurance type. Among 52,574 patients, the number of patients aged 65 years or older, hypertension was higher in the NHI group, but diabetes was higher in the MA group. Additionally, the MA group had more weekly dialysis sessions, and expensive drugs tended to be used less frequently. Regarding treatment outcomes, including laboratory test results, the MA group achieved significantly lower goals than the NHI group (p < 0.001). Furthermore, the mortality rate per 1,000 persons was 31 and 27 in the MA and NHI groups, respectively, and the mortality rate ratio was 1.2 (95% confidence interval [CI], 1.076-1.230). Moreover, the hazard ratio for mortality was 1.39 (95% CI, 1.30-1.49, p< 0.001) after adjusting for age, sex, causes of ESRD, and comorbidities. There were significant differences in the treatment and mortality indicators between the groups.”

According to the news editors, the research concluded: “Therefore, policy support should be strengthened to provide better medical services to MA beneficiaries undergoing HD.”

For more information on this research see: A comparative study of epidemiological characteristics, treatment outcomes, and mortality among patients undergoing hemodialysis by health insurance types: data from the Korean Renal Data System. Kidney Research and Clinical Practice, 2023. Kidney Research and Clinical Practice can be contacted at: Korean Soc Nephrology, 1401 Hyundai Kirim Bldg, 1330-18 Seocho 2-Dong, Seocho-Gu, Seoul 137-858, South Korea. (Elsevier - www.elsevier.com; Kidney Research and Clinical Practice - http://www.journals.elsevier.com/kidney-research-and-clinical-practice/)

The news correspondents report that additional information may be obtained from Soyoung Lee, Division of Nephrology, Dept. of Internal Medicine, Daejeon Eulji Medical Center, School of Medicine, Eulji University, Daejeon, South Korea. Additional authors for this research include Kyeong Min Kim, Jong Ho Shin and Mira Park.

The publisher’s contact information for the journal Kidney Research and Clinical Practice is: Korean Soc Nephrology, 1401 Hyundai Kirim Bldg, 1330-18 Seocho 2-Dong, Seocho-Gu, Seoul 137-858, South Korea.

(Our reports deliver fact-based news of research and discoveries from around the world.)